Tag: FOLD stock

In a filing, Amicus Therapeutics Inc revealed its Director BRADLEY CAMPBELL acquired Company’s shares for reported $87075.0 on Sep 03

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

In a filing, Amicus Therapeutics Inc revealed its President and CEO Campbell Bradley L unloaded Company’s shares for reported $77518.0

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Amicus Therapeutics

In a filing, Amicus Therapeutics Inc revealed its Director BRADLEY CAMPBELL acquired Company’s shares for reported $77325.0 on Aug 01

Amicus Therapeutics Inc’s filing revealed that its Director BRADLEY CAMPBELL acquired Company’s shares for reported $77325.0 on Aug 01 ’24.